You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: April 16, 2025

Drug Price Trends for NDC 13668-0463


✉ Email this page to a colleague

« Back to Dashboard


Average Pharmacy Cost for 13668-0463

Drug NameNDCPrice/Unit ($)UnitDate
ITRACONAZOLE 100 MG CAPSULE 13668-0463-30 0.89601 EACH 2025-03-19
ITRACONAZOLE 100 MG CAPSULE 13668-0463-30 0.85346 EACH 2025-02-19
ITRACONAZOLE 100 MG CAPSULE 13668-0463-30 0.76755 EACH 2025-01-22
ITRACONAZOLE 100 MG CAPSULE 13668-0463-30 0.77737 EACH 2024-12-18
ITRACONAZOLE 100 MG CAPSULE 13668-0463-30 0.70586 EACH 2024-11-20
>Drug Name>NDC>Price/Unit ($)>Unit>Date
Showing 1 to 5 of 5 entries

Best Wholesale Price for NDC 13668-0463

These are wholesale prices available to the US Federal Government which, by law, must be the best prices available under comparable terms and conditions
Drug NameVendorNDCCountPrice ($)Price/Unit ($)DatesPrice Type
No data available in table
>Drug Name>Vendor>NDC>Count>Price ($)>Price/Unit ($)>Dates>Price Type
Price type key: Federal Supply Schedule (FSS): generally available to all Federal Govt agencies / 'BIG4' prices: VA, DoD, Public Health & Coast Guard only / National Contracts (NC): Available to specific agencies
Showing 0 to 0 of 0 entries

Market Analysis and Price Projections for the Drug NDC: 13668-0463

Understanding the National Drug Code (NDC)

To analyze the market and price projections for a specific drug identified by its NDC, it is crucial to understand what the NDC represents. The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product. It includes the labeler code, product code, and package code, which together provide a comprehensive identifier for the drug[1].

Drug Identification and Listing

The NDC 13668-0463 would be associated with a specific drug product, including its strength, dosage form, and package size. This code is part of the FDA's Drug Registration and Listing System (DRLS) and is updated biannually by registered establishments to ensure accuracy and compliance with regulatory requirements[1].

Market Trends in Prescription Drugs

Price Increases and Affordability

Prescription drug prices have been a significant concern in recent years, with many drugs experiencing price increases, particularly in January and July of each year. According to ASPE analysis, the number of price increases has been rising, with over 3,000 drugs experiencing a price increase in January 2022 alone. The average price increase in January 2022 was nearly $150 per drug, representing a 10% increase[2].

Geographic Price Disparities

The prices of prescription drugs in the U.S. are significantly higher compared to other regions. For instance, the average price per unit in the U.S. was 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as in the rest of the world (excluding the U.S.) in 2022. This disparity is partly due to the drug mix in the U.S., which skews towards more expensive compounds[4].

Specific Drug Analysis

Trazodone Hydrochloride Example

While the specific NDC 13668-0463 is not detailed in the sources, we can use Trazodone Hydrochloride as an example to understand how pricing and market trends might apply. Trazodone Hydrochloride, an antidepressant, is listed under various NDC codes, such as those associated with Torrent Pharmaceuticals Limited[5].

Price Projections

Historical Price Increases

Given the historical trend of price increases, particularly in January and July, it is likely that the drug associated with NDC 13668-0463 could experience similar price adjustments. The average price increase in these months has been significant, with January 2022 seeing a 10% increase and July 2022 seeing a 7.8% increase[2].

Impact of Inflation and Market Dynamics

The overall inflation rate and market dynamics also play a crucial role in price projections. For instance, the Consumer Price Index (CPI-U) increased by 8.5% between July 2021 and July 2022, which can influence drug prices. However, drug price increases often exceed general inflation rates, indicating that other factors such as demand, supply chain costs, and regulatory changes also impact pricing[2].

Future Trends in Pharmaceutical Pricing

Role of AI and Data Analytics

The pharmaceutical industry is increasingly adopting artificial intelligence (AI) and leveraging external data to improve operations and decision-making. This trend is expected to continue, with AI applications becoming more prominent in predicting technical and regulatory success, which could indirectly influence pricing strategies[3].

International Market Comparisons

The U.S. market stands out for its high prescription drug prices compared to other regions. This disparity suggests that pricing strategies may vary significantly depending on the geographic market. For drugs marketed globally, understanding these differences is crucial for pricing and market access strategies[4].

Key Factors Influencing Price Projections

  • Regulatory Environment: Changes in regulatory requirements and compliance can affect pricing.
  • Market Demand: Fluctuations in demand due to changes in patient needs or competitor activity.
  • Supply Chain Costs: Increases in raw materials, manufacturing, or distribution costs.
  • Technological Advancements: Adoption of AI and other technologies that could reduce costs or improve efficiency.
  • Global Market Trends: Price comparisons and strategies in different geographic markets.

Conclusion

The market analysis and price projections for a drug with the NDC 13668-0463 would need to consider historical price trends, current market dynamics, and future technological and regulatory changes. Given the historical data, it is likely that this drug could experience price increases, particularly in January and July, and these increases could be influenced by broader market and economic factors.

Key Takeaways

  • NDC Codes: Unique identifiers for drug products, crucial for tracking and pricing.
  • Price Increases: Common in January and July, with significant average price increases.
  • Geographic Disparities: U.S. prices are significantly higher than in other regions.
  • AI and Data Analytics: Increasingly important in pharmaceutical operations and decision-making.
  • Regulatory and Market Factors: Influence pricing strategies and projections.

FAQs

What is the National Drug Code (NDC)?

The National Drug Code (NDC) is a unique, three-segment number that identifies a drug product, including the labeler code, product code, and package code.

Why do prescription drug prices increase more in January and July?

Historically, most prescription drug price increases occur in January and July, likely due to strategic pricing adjustments by pharmaceutical companies at the beginning of the year and mid-year.

How do U.S. prescription drug prices compare to other regions?

U.S. prescription drug prices are significantly higher than in other regions, with prices being 5.5 times as high as in the OECD (excluding the U.S.) and 7.7 times as high as in the rest of the world (excluding the U.S.).

What role does AI play in pharmaceutical pricing?

AI is increasingly used in the pharmaceutical industry for operations and decision-making, including predicting technical and regulatory success, which can indirectly influence pricing strategies.

How do regulatory changes affect drug pricing?

Regulatory changes can impact drug pricing by altering compliance requirements, affecting supply chains, and influencing market dynamics.

Sources

  1. FDA: National Drug Code Database Background Information.
  2. ASPE: Price Increases for Prescription Drugs, 2016-2022.
  3. Intelligencia.ai: 2025 Pharma Predictions: AI, Health Tech, and Data Trends to Watch.
  4. ASPE: International Market Size and Prices.
  5. DailyMed: Label: TRAZODONE HYDROCHLORIDE tablet.

More… ↓

⤷  Try for Free

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.